Bal Pharma reports 73.02% rise in Q4 consolidated net profit

31 May 2019 Evaluate

Bal Pharma has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported more than two fold rise in its net profit at Rs 3.57 crore for the quarter ended March 31, 2019 as compared to Rs 1.47 crore for the same quarter in the previous year. However, total income of the company decreased by 1.11% at Rs 57.03 crore for quarter under review as compared to Rs 57.67 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported marginal rise of 73.02% in its net profit at Rs 1.09 crore for the quarter ended March 31, 2019 as compared to Rs 0.63 crore for the corresponding quarter in the FY18. Total consolidated income of the company decreased 2.83% at Rs 54.21 crore for quarter under review as compared to Rs 55.79 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a rise of 10.29% in its net profit at Rs 6.54 crore as compared to Rs 5.93 crore for the previous year. Total income of company increased 6.77% at Rs 225.79 crore for year under review as compared to Rs 211.48 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted more than five-fold rise in its net profit at Rs 1.94 crore as compared to Rs 0.37 crore for the previous year. Total income of company increased by 6.01% at Rs 225.99 crore for year under review as compared to Rs 213.17 crore for year ended March 31, 2018.


Bal Pharma Share Price

101.98 -1.09 (-1.06%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...